(Q35691910)

9 August 2017

1 reference

title

Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design (English)

1 reference

9 August 2017

0 references

1

Peter A Lachenbruch

0 references

author name string

Amy S Rosenberg

2

1 reference

9 August 2017

Ezio Bonvini

3

1 reference

9 August 2017

Marc W Cavaillé-Coll

4

1 reference

9 August 2017

Robert B Colvin

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

American Journal of Transplantation

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

451-457

1 reference

Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Effect of histological damage on long-term kidney transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

International variation in histologic grading is large, and persistent feedback does not improve reproducibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Glomerular filtration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00386.X

10.1111/J.1600-6143.2004.00386.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference